BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1 AND Treatment
72 results:

  • 1. The Effects of Fucoidan Derived from
    Gupta D; Martinez DC; Puertas-Mejía MA; Hearnden VL; Reilly GC
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396762
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Risk Factors for treatment-Related Amenorrhea in Female Survivors of Childhood and Adolescent cancer: 10-Year Experiences at Oncofertility Clinic in Korean Tertiary Center.
    Park SJ; Choi JY; Kang HJ; Lee YJ; Lee YA; Han JY; Kim SW; Kim H; Ku SY
    J Adolesc Young Adult Oncol; 2024 Feb; 13(1):162-169. PubMed ID: 38064519
    [No Abstract]    [Full Text] [Related]  

  • 3. [Efficacy and safety of Anlotinib in the treatment of advanced sarcoma].
    Yan Q; Yao WT; Du XH; Guo LY; Fan YC
    Zhonghua Zhong Liu Za Zhi; 2023 Oct; 45(10):904-910. PubMed ID: 37875427
    [No Abstract]    [Full Text] [Related]  

  • 4. Factors Associated with Long-Term Prostate cancer Survival after Palliative Radiotherapy to a bone Metastasis and Contemporary Palliative Systemic Therapy: A Retrospective, Population-Based Study.
    Venugopal B; Shahhat S; Beck J; Hanumanthappa N; Ong AD; Dubey A; Koul R; Bashir B; Chowdhury A; Sivananthan G; Kim JO
    Curr Oncol; 2023 Jun; 30(6):5560-5573. PubMed ID: 37366903
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The FBXO32/atr/ATM axis acts as a molecular switch to control the sensitivity of osteosarcoma cells to irradiation through its regulation of EXO1 expression.
    Lu Y; Huang P; Li Y; Liu W; Li J; Zhao R; Feng H; Shi C; Cao G
    Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(5):842-852. PubMed ID: 37227155
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Venetoclax consolidation in high-risk CLL treated with ibrutinib for ≥1 year achieves a high rate of undetectable MRD.
    Thompson PA; Keating MJ; Ferrajoli A; Jain N; Peterson CB; Garg N; Wang SA; Jorgensen JL; Kadia TM; Bose P; Pemmaraju N; Short NJ; Wierda WG
    Leukemia; 2023 Jul; 37(7):1444-1453. PubMed ID: 37138019
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Synergistic anticancer activity of combined atr and ribonucleotide reductase inhibition in Ewing's sarcoma cells.
    Sturm MJ; Henao-Restrepo JA; Becker S; Proquitté H; Beck JF; Sonnemann J
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8605-8617. PubMed ID: 37097390
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Frailty and sarcopenia within the earliest national Dutch childhood cancer survivor cohort (DCCSS-LATER): a cross-sectional study.
    van Atteveld JE; de Winter DTC; Pluimakers VG; Fiocco M; Nievelstein RAJ; Hobbelink MGG; Kremer LCM; Grootenhuis MA; Maurice-Stam H; Tissing WJE; de Vries ACH; Loonen JJ; van Dulmen-den Broeder E; van der Pal HJH; Pluijm SMF; van der Heiden-van der Loo M; Versluijs AB; Louwerens M; Bresters D; van Santen HM; Hoefer I; van den Berg SAA; den Hartogh J; Hoeijmakers JHJ; Neggers SJCMM; van den Heuvel-Eibrink MM;
    Lancet Healthy Longev; 2023 Apr; 4(4):e155-e165. PubMed ID: 37003274
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Sarcoma brain metastases: Tertiary cancer center experience.
    Ababneh HS; Muhsen B; Fares AS; Hirbawi H; Awabdeh TA; Hussaini MA; Amarin R; Mousa AA; Salah S
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S758-S763. PubMed ID: 38384052
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Identifying patients with malignant spinal cord compression (MSCC) near end of life who can benefit from palliative radiotherapy.
    Rades D; Segedin B; Schild SE; Lomidze D; Veninga T; Cacicedo J
    Radiat Oncol; 2022 Aug; 17(1):143. PubMed ID: 35978340
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney cancer Consortium (TKCC) Database.
    Yekedüz E; Karakaya S; Ertürk İ; Tural D; Uçar G; Şentürk Öztaş N; Arıkan R; Hızal M; Küçükarda A; Sever ÖN; Arslan Ç; Can O; Kılıçkap S; Yazgan C; Karadurmuş N; Şendur MA; Çiçin İ; Demirci U; Özgüroğlu M; Öksüzoğlu B; Ürün Y
    Clin Genitourin Cancer; 2023 Feb; 21(1):175-182. PubMed ID: 35970759
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. p53 as a unique target of action of cisplatin in acute leukaemia cells.
    Kumar S; Tchounwou PB
    J Cell Mol Med; 2022 Sep; 26(17):4727-4739. PubMed ID: 35946055
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Quercetin Augments Cisplatin-Induced Apoptosis, DNA Damage Response, and MiR-22 Expression While It Prevents DNA Repair in Osteosarcoma Cells.
    Malakoti F; Majidinia M; Ahmadi Y; Yousefi B; Shanebandi D
    Drug Res (Stuttg); 2022 Sep; 72(7):378-384. PubMed ID: 35724673
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study.
    Dimitriou F; Namikawa K; Reijers ILM; Buchbinder EI; Soon JA; Zaremba A; Teterycz P; Mooradian MJ; Armstrong E; Nakamura Y; Vitale MG; Tran LE; Bai X; Allayous C; Provent-Roy S; Indini A; Bhave P; Farid M; Kähler KC; Mehmi I; Atkinson V; Klein O; Stonesifer CJ; Zaman F; Haydon A; Carvajal RD; Hamid O; Dummer R; Hauschild A; Carlino MS; Mandala M; Robert C; Lebbe C; Guo J; Johnson DB; Ascierto PA; Shoushtari AN; Sullivan RJ; Cybulska-Stopa B; Rutkowski P; Zimmer L; Sandhu S; Blank CU; Lo SN; Menzies AM; Long GV
    Ann Oncol; 2022 Sep; 33(9):968-980. PubMed ID: 35716907
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genotoxicity, oxidative stress and transcriptomic effects of Nitenpyram on human bone marrow mesenchymal stem cells.
    Liu W; Li Z; Cui X; Luo F; Zhou C; Zhang J; Xing L
    Toxicol Appl Pharmacol; 2022 Jul; 446():116065. PubMed ID: 35568224
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. FT-IR Spectral Signature of Sensitive and Multidrug-Resistant Osteosarcoma Cell-Derived Extracellular Nanovesicles.
    Perut F; Graziani G; Roncuzzi L; Zini N; Avnet S; Baldini N
    Cells; 2022 Feb; 11(5):. PubMed ID: 35269400
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Ouabain Induces DNA Damage in Human Osteosarcoma U-2 OS Cells and Alters the Expression of DNA Damage and DNA Repair-associated Proteins.
    Yang JL; Yang MD; Chen JC; Lu KW; Huang YP; Peng SF; Chueh FS; Liu KC; Lin TS; Chen PY; Chen WJ
    In Vivo; 2021; 35(5):2687-2696. PubMed ID: 34410957
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Live-cell atr-FTIR spectroscopy as a novel bioanalytical tool for cell glucose metabolism research.
    Poonprasartporn A; Chan KLA
    Biochim Biophys Acta Mol Cell Res; 2021 Jun; 1868(7):119024. PubMed ID: 33831457
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Retrobulbar Hemangioblastomas in von Hippel-Lindau Disease: Clinical Course and Management.
    Alvarez R; Mastorakos P; Hogan E; Scott G; Lonser RR; Wiley HE; Chew EY; Chittiboina P
    Neurosurgery; 2021 Apr; 88(5):1012-1020. PubMed ID: 33442737
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Temporal modulation of the NF-κB RelA network in response to different types of DNA damage.
    Campbell AE; Ferraz Franco C; Su LI; Corbin EK; Perkins S; Kalyuzhnyy A; Jones AR; Brownridge PJ; Perkins ND; Eyers CE
    Biochem J; 2021 Feb; 478(3):533-551. PubMed ID: 33438746
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.